70 results
S-1/A
EX-10.3
NRIX
Nurix Therapeutics Inc
20 Jul 20
IPO registration (amended)
6:32am
performance goals and other criteria.
5.2. Date of Grant. The date of grant of an Option will be the date on which the Committee makes … to be used to measure performance goals, if any; and (c) determine the number of Shares that may be awarded to the Participant. Performance Periods may
8-K
EX-99.1
NRIX
Nurix Therapeutics Inc
13 Apr 23
Nurix Therapeutics Reports First Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
4:02pm
. “The advancement of our IRAK4 program marks the achievement of one of our key goals in 2023 and highlights the capability of our platform to create drug … and results of preclinical studies and clinical trials; (iii) Nurix’s ability to fund development activities and achieve development goals; (iv
8-K
EX-99.2
qfdp7dldhei2n
10 Jan 22
Other Events
7:11am
8-K
EX-99.2
khpy yh40412829z0dz9
8 Jan 24
Regulation FD Disclosure
7:03am
8-K
u0gny0
10 Jan 22
Other Events
7:11am
8-K
p6xhs
8 Jan 24
Regulation FD Disclosure
7:03am
8-K
EX-99.1
6e2ffz
27 Oct 21
Other Events
7:01am
8-K
61g0pe5oanfm7
7 Dec 20
Regulation FD Disclosure
6:06am
10-K
EX-10.7
md71ge6lju
16 Feb 21
Annual report
4:11pm
S-1/A
EX-10.6
6dg78 8oz57000p
20 Jul 20
IPO registration (amended)
6:32am
S-1/A
EX-10.7
oaeor3tit1qrchqhka
20 Jul 20
IPO registration (amended)
6:32am
S-1/A
EX-10.5
h0bc54h vp
20 Jul 20
IPO registration (amended)
6:32am
8-K
1mbjr l0y0
7 Sep 23
Entry into a Material Definitive Agreement
7:02am
8-K
EX-99.1
0gwhvta
11 Mar 24
Nurix Therapeutics Announces U.S. FDA Lifts Partial Clinical Hold on NX-2127 Phase 1 Trial
7:02am
8-K
EX-99.1
trodrk
10 Jan 22
Other Events
7:11am
8-K
sanxr
21 Jun 21
Departure of Directors or Certain Officers
4:17pm